Oral tranexamic acid for the treatment of melasma: evidence and experience-based consensus statement from Indian experts

• Päätekijät: Kiran Godse (Tekijä), Rashmi Sarkar (Tekijä), Venkataram Mysore (Tekijä), Manunath M Shenoy (Tekijä), Manas Chatterjee (Tekijä), Rajetha Damisetty (Tekijä), Swapnil Shah (Tekijä), Maya Vedamurthy (Tekijä), Sanjeev Aurangabadkar (Tekijä), Chakravarthi Srinivas (Tekijä), Anil Ganjoo (Tekijä), Sudip Das (Tekijä), Anant Patil (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Wolters Kluwer Medknow Publications, 2023-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Melasma, a chronic pigmentary skin condition mainly affecting the face, remains a challenge despite the availability of several options for treatment. Many melasma patients are not satisfied with treatment outcomes. Tranexamic acid (TXA), an anti-fibrinolytic drug has shown promising results in pati...